Literature DB >> 9635549

Dopaminergic agents and stimulants as antidepressant augmentation strategies.

A A Nierenberg1, D Dougherty, J F Rosenbaum.   

Abstract

Dopaminergic agents and stimulants have been used to manage depression when conventional antidepressant treatments fail. We reviewed evidence for the role of dopaminergic dysfunction in depression, the use of dopaminergic agents as antidepressants, and the use of dopaminergic agents and stimulants as antidepressant adjuncts. Dopamine may be part of the pathophysiology of depression for a subset of patients. When used with caution and an appreciation of the potential risk of abuse, dopaminergic agents and stimulants may be useful for patients refractory to antidepressants alone.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9635549

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  9 in total

Review 1.  [Antidepressant effects of dopamine agonists. Experimental and clinical findings].

Authors:  M R Lemke
Journal:  Nervenarzt       Date:  2007-01       Impact factor: 1.214

Review 2.  Assessing the roles of stimulants/stimulant-like drugs and dopamine-agonists in the treatment of bipolar depression.

Authors:  Bernardo Dell'Osso; Terence A Ketter; Laura Cremaschi; Gregorio Spagnolin; A Carlo Altamura
Journal:  Curr Psychiatry Rep       Date:  2013-08       Impact factor: 5.285

3.  Interaction of DRD2TaqI, COMT, and ALDH2 genes associated with bipolar II disorder comorbid with anxiety disorders in Han Chinese in Taiwan.

Authors:  Ming-Chuan Hu; Sheng-Yu Lee; Tzu-Yun Wang; Yun-Hsuan Chang; Shiou-Lan Chen; Shih-Heng Chen; Chun-Hsien Chu; Chen-Lin Wang; I Hui Lee; Po See Chen; Yen Kuang Yang; Ru-Band Lu
Journal:  Metab Brain Dis       Date:  2014-11-29       Impact factor: 3.584

Review 4.  Stimulant drugs.

Authors:  P J Santosh; E Taylor
Journal:  Eur Child Adolesc Psychiatry       Date:  2000       Impact factor: 4.785

Review 5.  Psychiatric disorders and sleep.

Authors:  Andrew D Krystal
Journal:  Neurol Clin       Date:  2012-11       Impact factor: 3.806

Review 6.  Advances in the treatment of depression.

Authors:  Paul E Holtzheimer; Charles B Nemeroff
Journal:  NeuroRx       Date:  2006-01

7.  Genetic biomarkers of depression.

Authors:  Anand Tamatam; Farhath Khanum; Amarinder Singh Bawa
Journal:  Indian J Hum Genet       Date:  2012-01

Review 8.  Future prospects in depression research.

Authors:  Paul E Holtzheimer; Charles B Nemeroff
Journal:  Dialogues Clin Neurosci       Date:  2006       Impact factor: 5.986

9.  Effectiveness of methylphenidate as augmentation therapy after failure of adjunctive neuromodulation for patients with treatment-refractory bipolar depression: a case report.

Authors:  Marc Adida; Jean-Michel Azorin
Journal:  Neuropsychiatr Dis Treat       Date:  2014-04-02       Impact factor: 2.570

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.